Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Requalite GmbH is a medical device Regulatory Affairs and Clinical Study services company based in Munich, Germany. It serves manufacturers of medical devices and in vitro diagnostic devices, providing EU MDR and IVDR compliance support as well as full CRO clinical study services. The available text indicates that its core goal is to help companies prepare technical documentation, audits, and submission materials for notified bodies and competent authorities in order to obtain CE marking.
Based on the disclosed information, Requalite’s services cover regulatory affairs, clinical studies, analytical studies, and quality management. On the regulatory side, it supports documents such as technical files, performance evaluations, clinical evaluations, biocompatibility reports, QMS, RMS, post-market reports, and IFUs. On the clinical side, it emphasizes study planning, preparation, execution, and reporting. On the quality side, it mentions establishing ISO 9001-compliant quality and process management systems and states that it is ISO 9001 certified. In terms of team expertise, its medical writers mostly have PhDs and research backgrounds, covering fields such as molecular biology, genetics, immunology, oncology, hematology, cardiovascular medicine, and neurology.
The website does not disclose packages, pricing, payment methods, or service timelines. Judging by the nature of the business, it appears closer to project-based consulting/CRO services than a standardized subscription SaaS. The text does not specify whether there is an online platform, customer portal, API, third-party integrations, or permission-based collaboration features.
The strengths are its clear positioning and focus on EU medical device compliance, covering key areas such as MDR/IVDR, technical documentation, clinical/performance evaluation, and quality management. Its ISO 9001 certification and professional team background also add credibility. The weaknesses are that the website contains a large amount of Lorem ipsum and family clinic template content, suggesting insufficient content cleanup and affecting its professional image. It also lacks case studies, pricing, delivery workflow details, data security information, and explanations of any software capabilities.
It is suitable for medical device and IVD companies preparing to enter the EU market and needing CE marking submissions, MDR/IVDR technical documentation, clinical evaluation, or CRO support. It is not suitable for users looking for a standard SaaS product, an online compliance management system, or self-service enterprise software.
The extracted text mentions that Requalite attended CMEF China 2023 and has a China Business Development Representative, but it does not provide evidence of availability from mainland China. Therefore, its access status in China is rated as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on requalite.com official site.
requalite.com is an Germany Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach requalite.com directly.